These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 19534792)

  • 1. Recent advances in biomedical applications of accelerator mass spectrometry.
    Hah SS; Henderson PT; Turteltaub KW
    J Biomed Sci; 2009 Jun; 16(1):54. PubMed ID: 19534792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current perspectives of 14C-isotope measurement in biomedical accelerator mass spectrometry.
    Lappin G; Garner RC
    Anal Bioanal Chem; 2004 Jan; 378(2):356-64. PubMed ID: 14624324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomedical applications of accelerator mass spectrometry-isotope measurements at the level of the atom.
    Barker J; Garner RC
    Rapid Commun Mass Spectrom; 1999; 13(4):285-93. PubMed ID: 10097404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerator mass spectrometry.
    Hellborg R; Skog G
    Mass Spectrom Rev; 2008; 27(5):398-427. PubMed ID: 18470926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of accelerator mass spectrometry for pharmacological and toxicological research.
    Brown K; Tompkins EM; White IN
    Mass Spectrom Rev; 2006; 25(1):127-45. PubMed ID: 16059873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomedical accelerator mass spectrometry: recent applications in metabolism and pharmacokinetics.
    Lappin G; Stevens L
    Expert Opin Drug Metab Toxicol; 2008 Aug; 4(8):1021-33. PubMed ID: 18680438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerator mass spectrometry in pharmaceutical research and development--a new ultrasensitive analytical method for isotope measurement.
    Garner RC
    Curr Drug Metab; 2000 Sep; 1(2):205-13. PubMed ID: 11465084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attomole detection of 3H in biological samples using accelerator mass spectrometry: application in low-dose, dual-isotope tracer studies in conjunction with 14C accelerator mass spectrometry.
    Dingley KH; Roberts ML; Velsko CA; Turteltaub KW
    Chem Res Toxicol; 1998 Oct; 11(10):1217-22. PubMed ID: 9778319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerator mass spectrometry for biomedical research.
    Brown K; Dingley KH; Turteltaub KW
    Methods Enzymol; 2005; 402():423-43. PubMed ID: 16401518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accelerator mass spectrometry of small biological samples.
    Salehpour M; Forsgard N; Possnert G
    Rapid Commun Mass Spectrom; 2008 Dec; 22(23):3928-34. PubMed ID: 18980253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological and biomedical (14)C-accelerator mass spectrometry and graphitization of carbonaceous samples.
    Chung IM; Kim SH
    Analyst; 2013 Jun; 138(12):3347-55. PubMed ID: 23626987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroscience and accelerator mass spectrometry.
    Palmblad M; Buchholz BA; Hillegonds DJ; Vogel JS
    J Mass Spectrom; 2005 Feb; 40(2):154-9. PubMed ID: 15706618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on DNA adduction with heterocyclic amines by accelerator mass spectrometry: a new technique for tracing isotope-labelled DNA adduction.
    Turteltaub KW; Vogel JS; Frantz CE; Fultz E
    IARC Sci Publ; 1993; (124):293-301. PubMed ID: 8225498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accelerator mass spectrometry in biomedical dosimetry: relationship between low-level exposure and covalent binding of heterocyclic amine carcinogens to DNA.
    Turteltaub KW; Felton JS; Gledhill BL; Vogel JS; Southon JR; Caffee MW; Finkel RC; Nelson DE; Proctor ID; Davis JC
    Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5288-92. PubMed ID: 2371271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerator mass spectrometry-enabled studies: current status and future prospects.
    Arjomand A
    Bioanalysis; 2010 Mar; 2(3):519-41. PubMed ID: 20440378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of graphite target for biological/biomedical/environmental applications of 14C-accelerator mass spectrometry.
    Kim SH; Kelly PB; Ortalan V; Browning ND; Clifford AJ
    Anal Chem; 2010 Mar; 82(6):2243-52. PubMed ID: 20163100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel 14C-postlabeling assay using accelerator mass spectrometry for the detection of O6-methyldeoxy-guanosine adducts.
    Tompkins EM; Farmer PB; Lamb JH; Jukes R; Dingley K; Ubick E; Turteltaub KW; Martin EA; Brown K
    Rapid Commun Mass Spectrom; 2006; 20(5):883-91. PubMed ID: 16470516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Big physics, small doses: the use of AMS and PET in human microdosing of development drugs.
    Lappin G; Garner RC
    Nat Rev Drug Discov; 2003 Mar; 2(3):233-40. PubMed ID: 12612650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Techniques: the application of accelerator mass spectrometry to pharmacology and toxicology.
    White IN; Brown K
    Trends Pharmacol Sci; 2004 Aug; 25(8):442-7. PubMed ID: 15276714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of a 250 kV single-stage accelerator mass spectrometer with a 5 MV tandem accelerator mass spectrometer--fitness for purpose in bioanalysis.
    Young GC; Corless S; Felgate CC; Colthup PV
    Rapid Commun Mass Spectrom; 2008 Dec; 22(24):4035-42. PubMed ID: 19009519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.